A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
Open Access
- 3 September 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1648868
Abstract
A deeper understanding of the immune-based pathogenesis of alopecia areata is essential for the development of novel targeted therapies. Compared to cytokines, chemokines exhibit substantially higher serum concentrations, offering a more robust approach for large-scale immune profiling. However, the complexity of chemokine interactions presents challenges in defining their precise roles in AA. To explore these dynamics, we conducted a scoping review and meta-analysis of 46 original research articles examining chemokine expression in skin and blood samples from AA patients; meta-analysis was performed when three or more studies assessed the same chemokine in comparable groups. Th1-associated chemokines—including CXCL9, CXCL10, CCL5, and CXCL11—were consistently elevated in AA, reflecting the known IFN-γ–driven response. A distinct Th2 chemokine signature was also observed, with increased levels of CCL13, CCL17, CCL22, and CX3CL1. Additionally, elevated levels of CCL2, CCL3, CCL4 (monocyte/dendritic cell recruitment), and CCL11, CCL24, and CCL26 (eosinophil recruitment) suggest the involvement of immune pathways beyond classical T helper subsets. Meta-analysis confirmed significantly elevated serum levels of CXCL9 (p = 0.003), CXCL10 (p = 0.004), CXCL8 (p < 0.001), and CCL17 (p < 0.001). These findings reveal a complex chemokine profile in AA, dominated by Th1 activity but also implicating Th2 and other immune pathways, highlighting the potential benefit of broader immunomodulatory strategies to address the multifaceted immune dysregulation underlying the disease.Keywords
This publication has 74 references indexed in Scilit:
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational studyArchives of Dermatological Research, 2024
- Gel-mediated recruitment of conventional type 1 dendritic cells potentiates the therapeutic effects of radiotherapyBiomaterials, 2024
- Clinical characteristics and immune profiles of patients with immune-mediated alopecia associated with COVID-19 vaccinationsClinical Immunology, 2023
- Two‐sided influence of dupilumab on alopecia areata co‐existing with severe atopic dermatitis: A case series and literature reviewJournal of Cutaneous Immunology and Allergy, 2022
- The MCP‐1 rs1024611 and MTHFR rs1801133 gene variations and expressions in alopecia areata: A pilot studyImmunity, Inflammation and Disease, 2021
- Immunopathogenesis of alopecia areataCurrent Research in Immunology, 2021
- The multifarious roles of the chemokine CXCL14 in cancer progression and immune responsesMolecular Carcinogenesis, 2020
- CCR5 is a novel target for the treatment of experimental alopecia areataJournal of Cutaneous Immunology and Allergy, 2020
- Macrophage Inflammatory Protein-1 Alpha (MIP-1 alpha)/CCL3: As a Biomarker2015
- Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammationThe Journal of Pathology, 2001